Processa Pharmaceuticals (PCSA) News and press releases

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

18 Sep 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket

18 Sep 23

News, Penny Stocks, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers T2 Biosystems, Inc. (NASDAQ: TTOO) shares rose 44.4% to $0.4003 in pre-market trading. T2 Biosystems said it issued inducement awards to four new employees.

12 Health Care Stocks Moving In Friday's After-Market Session

15 Sep 23

Movers

Stocks That Hit 52-Week Lows On Monday

11 Sep 23

Options

Monday's session saw 175 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Wednesday

6 Sep 23

Options

On Wednesday, 179 companies reached new 52-week lows.

Why Olin Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

1 Sep 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) surged 181.1% to $3.63. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 148.5% to $18.14.

Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

1 Sep 23

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 53.4% to $0.2147 in pre-market trading after the company announced it received an Underwriting Clearance Notice for a $70 million coupon.

12 Health Care Stocks Moving In Thursday's After-Market Session

31 Aug 23

Movers

Stocks That Hit 52-Week Lows On Monday

28 Aug 23

Options

During Monday, 102 stocks hit new 52-week lows.

12 Health Care Stocks Moving In Friday's After-Market Session

18 Aug 23

Movers

12 Health Care Stocks Moving In Tuesday's After-Market Session

4 Jul 23

Movers

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

6 Sep 23

Press Releases

HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next generation of

Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care

17 Aug 23

Press Releases

Interim analysis of Phase 1B data suggests Processa's novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient HANOVER, MD, Aug. 17, 2023

Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference

10 Aug 23

Press Releases

HANOVER, MD, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company now focused on developing the next generation of

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

8 Aug 23

Press Releases

HANOVER, MD, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focusing on developing the next generation of